Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Patrick N. A. Harris(The University of Queensland), John Ferguson(University of Florida)
Cited by 122
Related Papers
Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
|Nature Reviews Urology|2015|367
Health Risks of Flood Disasters
|Clinical Infectious Diseases|2018|253
Colistin resistance: a major breach in our last line of defence
|The Lancet Infectious Diseases|2015|206